Skip to main content

Find Clinical Trials

Home
Conditions
Leukemia, T-Cell

Clinical trial condition

Leukemia, T-Cell

Explore clinical trials studying Leukemia, T-Cell. Study availability and eligibility vary by location and protocol.

144 public trials 25 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, T-Cell trial results

Completed

A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies

NCT01384513

Conditions: Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), +111 more
Locations: Thomas Jefferson University Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Belinostat Therapy With Zidovudine for Adult T-Cell Leukemia-Lymphoma

NCT02737046

Conditions: ATLL, Adult T-Cell Leukemia-Lymphoma, Hematologic Diseases, +11 more
Locations: University of Miami Miami, Florida, United States

View Trial Details

Completed

Romidepsin Maintenance After Allogeneic Stem Cell Transplantation

NCT02512497

Conditions: Cutaneous T-Cell Lymphoma, Hematologic Diseases, Hemic and Lymphatic Diseases, +22 more
Locations: The Ohio State University Cancer Center Columbus, Ohio, United States

View Trial Details

Completed

Safety, PK, PD, Clinical Activity of KT-333 in Adult Patients With Refractory Lymphoma, Large Granular Lymphocytic Leukemia, Solid Tumors

NCT05225584

Conditions: Cutaneous T-cell Lymphoma (CTCL), Hematologic Diseases, Hemic and Lymphatic Diseases, +22 more
Locations: UC Irvine Health-Chao Family Comprehensive Cancer Center Orange, California, United States

Norton Cancer Institute Louisville, Kentucky, United States

Henry Ford Hospital Detroit, Michigan, United States

Hackensack University Medical Center, John Theurer Cancer Center Hackensack, New Jersey, United States

View all 13 locations

View Trial Details

Completed

Letermovir for the Prevention of Cytomegalovirus Reactivation in Patients With Hematological Malignancies Treated With Alemtuzumab

NCT04312841

Conditions: B-Cell Prolymphocytic Leukemia, Chronic Disease, Chronic Lymphocytic Leukemia, +28 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Completed

Itacitinib and Alemtuzumab in Treating Patients With T-Cell Prolymphocytic Leukemia

NCT03989466

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

KW-0761 or Investigator's Choice in Subjects With Previously Treated Adult T-cell Leukemia-Lymphoma (ATL)

NCT01626664

Conditions: Adult T-Cell Leukemia-Lymphoma, Hematologic Diseases, Hemic and Lymphatic Diseases, +12 more
Locations: Cedars-Sinai Medical Center Los Angeles, California, United States

University of Miami / Sylvester Comprehensive Cancer Center Miami, Florida, United States

Northwestern University Chicago, Illinois, United States

National Cancer Institute Bethesda, Maryland, United States

View all 20 locations

View Trial Details

Completed

Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant

NCT01588015

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +198 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Completed

CPI-613 and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma

NCT02168140

Conditions: Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma, Adult Mixed Cellularity Hodgkin Lymphoma, +40 more
Locations: Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States

Abramson Cancer Center Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Phase II Trial of LMB-2, Fludarabine and Cyclophosphamide for Adult T-Cell Leukemia

NCT00924170

Conditions: Adult T-Cell Leukemia (ATL), Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details